UNITED STATES PRECISION MEDICINE MARKET FORECAST 2021-2026

The United States precision medicine market is predicted to register a CAGR of 9.76%, over the forecast years. The country’s market growth is accredited to factors like, the initiatives introduced by the government and the increasing demand for precision medicine. The base year considered for the market study is 2020, and the forecast years are from 2021 to 2026.

united-states-precision-medicine-market

Over the last decade, the United States has undertaken several initiatives to promote the adoption of precision medicine. For instance, Sync for Genes, launched in 2017, principally aims to standardize sharing genomic information between laboratories, patients, providers, and researchers. The program also accelerates the usage and development of industry-supported standards, facilitating the integration and sharing of genomic data in a relatively usable and consistent manner. Besides, it also complements the efforts established by Sync for Science, in terms of sharing clinical data from electronic health records (EHRs).

On the other hand, the Advancing Standards for Precision Medicine was launched in 2018. The initiative’s main objective is to identify and recommend the different types of sensors, wearables, and social determinants of health data, particularly for standardization. Furthermore, these programs have led to increased awareness regarding the advantages and efficiency of precision medicine across the United States’ population, thereby augmenting its demand. As a result, these factors are projected to supplement the country’s market growth, over the forecast period.

Pfizer Inc, headquartered in the United States, is a biopharmaceutical company that develops, manufactures, and markets products like vaccines, and medicines. Also, the firm offers its products for treating metabolic, cardiovascular, and respiratory diseases and conditions, infection, cancer, inflammation, ophthalmic diseases, pain, neurological problems, gastrointestinal diseases, tissue repair, orphan diseases, and women’s health issues, among others.

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. KEY GROWTH ENABLERS
    5. KEY CHALLENGES
  3. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON PRECISION MEDICINE MARKET
    2. KEY INVESTMENT INSIGHTS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. THREAT OF NEW ENTRY
      2. THREAT OF SUBSTITUTION
      3. BUYER’S POWER
      4. SUPPLIER’S POWER
      5. COMPETITIVE RIVALRY
    4. OPPORTUNITY MATRIX
    5. VENDOR LANDSCAPE
    6. TECHNOLOGIES RELATED TO PRECISION MEDICINE
    7. SUPPLY CHAIN ANALYSIS
    8. REGULATORY FRAMEWORK
  4. MARKET BY APPLICATION
    1. ONCOLOGY
    2. INFECTIOUS DISEASES
    3. NEUROLOGY/PHYSIATRY
    4. CARDIOVASCULAR
    5. LIFESTYLE AND ENDOCRINOLOGY
    6. GASTROENTEROLOGY
    7. OTHER APPLICATIONS
  5. MARKET BY COMPONENT
    1. APPLIED SCIENCE
      1. GENOMICS
        1. PCR
        2. PM NGS
        3. GENOME EDITING
        4. OTHER GENOMICS TECHNOLOGIES
      2. PHARMACOGENOMICS
      3. OTHER APPLIED SCIENCES
    2. PRECISION THERAPEUTICS
      1. CLINICAL TRIALS
      2. CELL THERAPY
      3. DRUG DISCOVERY AND RESEARCH
      4. GENE THERAPY
    3. PRECISION DIAGNOSTICS
      1. MOLECULAR DIAGNOSTICS
        1. NON-INVASIVE PRENATAL TESTING (NIPT)
        2. COMPANION DIAGNOSTICS
        3. LIQUID BIOPSY
        4. OTHER MOLECULAR DIAGNOSTICS
      2. MEDICAL IMAGING
        1. IMAGING ANALYTICS
        2. IMAGING COMPUTER-AIDED DETECTION (CADX)
    4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY
      1. CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
      2. BIG DATA ANALYTICS
      3. IT INFRASTRUCTURE
      4. GENOMICS INFORMATICS
      5. IN-SILICO INFORMATICS
      6. MOBILE HEALTH
  6. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. MERGERS & ACQUISITIONS
      2. PRODUCT LAUNCHES & DEVELOPMENTS
      3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
      4. BUSINESS EXPANSIONS/ APPROVALS/ ANNOUNCEMENTS
    2. COMPANY PROFILES
      1. ABBOTT LABORATORIES
      2. BIO-RAD LABORATORIES INC
      3. ELI LILLY & COMPANY
      4. F. HOFFMANN-LA ROCHE
      5. NOVARTIS AG
      6. PFIZER INC
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PRECISION MEDICINE

TABLE 2: UNITED STATES PRECISION MEDICINE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: UNITED STATES PRECISION MEDICINE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 4: UNITED STATES PRECISION MEDICINE MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: UNITED STATES PRECISION MEDICINE MARKET, BY COMPONENT, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 6: UNITED STATES APPLIED SCIENCE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: UNITED STATES APPLIED SCIENCE MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 8: UNITED STATES GENOMICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: UNITED STATES GENOMICS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 10: UNITED STATES PRECISION THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: UNITED STATES PRECISION THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 12: UNITED STATES PRECISION DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 13: UNITED STATES PRECISION DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 14: UNITED STATES MOLECULAR DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 15: UNITED STATES MOLECULAR DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 16: UNITED STATES MEDICAL IMAGING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 17: UNITED STATES MEDICAL IMAGING MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 18: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 19: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 20: LIST OF MERGERS & ACQUISITIONS

TABLE 21: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS

TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: CHRONIC CONDITIONS IN PATIENTS HOSPITALIZED WITH COVID-19 IN THE UNITED STATES

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: KEY INVESTMENT INSIGHTS

FIGURE 6: UNITED STATES PRECISION MEDICINE MARKET, BY APPLICATION, IN 2020

FIGURE 7: UNITED STATES PRECISION MEDICINE MARKET, BY ONCOLOGY, 2021-2026 (IN $ MILLION)

FIGURE 8: UNITED STATES PRECISION MEDICINE MARKET, BY INFECTIOUS DISEASES, 2021-2026 (IN $ MILLION)

FIGURE 9: UNITED STATES PRECISION MEDICINE MARKET, BY NEUROLOGY/PHYSIATRY, 2021-2026 (IN $ MILLION)

FIGURE 10: UNITED STATES PRECISION MEDICINE MARKET, BY CARDIOVASCULAR, 2021-2026 (IN $ MILLION)

FIGURE 11: UNITED STATES PRECISION MEDICINE MARKET, BY LIFESTYLE AND ENDOCRINOLOGY, 2021-2026 (IN $ MILLION)

FIGURE 12: UNITED STATES PRECISION MEDICINE MARKET, BY GASTROENTEROLOGY, 2021-2026 (IN $ MILLION)

FIGURE 13: UNITED STATES PRECISION MEDICINE MARKET, BY OTHER APPLICATIONS,2021-2026 (IN $ MILLION)

FIGURE 14: UNITED STATES PRECISION MEDICINE MARKET, BY COMPONENT, IN 2020

FIGURE 15: UNITED STATES PRECISION MEDICINE MARKET, BY APPLIED SCIENCE, 2021-2026 (IN $ MILLION)

FIGURE 16: UNITED STATES APPLIED SCIENCE MARKET, BY GENOMICS, 2021-2026 (IN $ MILLION)

FIGURE 17: UNITED STATES GENOMICS MARKET, BY PCR, 2021-2026 (IN $ MILLION)

FIGURE 18: UNITED STATES GENOMICS MARKET, BY PM NGS, 2021-2026 (IN $ MILLION)

FIGURE 19: UNITED STATES GENOMICS MARKET, BY GENOME EDITING, 2021-2026 (IN $ MILLION)

FIGURE 20: UNITED STATES GENOMICS MARKET, BY OTHER GENOMICS TECHNOLOGIES, 2021-2026 (IN $ MILLION)

FIGURE 21: UNITED STATES APPLIED SCIENCE MARKET, BY PHARMACOGENOMICS, 2021-2026 (IN $ MILLION)

FIGURE 22: BIOMARKER’S ROLE IN PHARMACOGENOMICS

FIGURE 23: UNITED STATES APPLIED SCIENCES MARKET, BY OTHER APPLIED SCIENCES, 2021-2026 (IN $ MILLION)

FIGURE 24: UNITED STATES PRECISION MEDICINE MARKET, BY PRECISION THERAPEUTICS, 2021-2026 (IN $ MILLION)

FIGURE 25: UNITED STATES PRECISION THERAPEUTICS MARKET, BY CLINICAL TRIALS, 2021-2026 (IN $ MILLION)

FIGURE 26: UNITED STATES PRECISION THERAPEUTICS MARKET, BY CELL THERAPY, 2021-2026 (IN $ MILLION)

FIGURE 27: UNITED STATES PRECISION THERAPEUTICS MARKET, BY DRUG DISCOVERY AND RESEARCH, 2021-2026 (IN $ MILLION)

FIGURE 28: UNITED STATES PRECISION THERAPEUTICS MARKET, BY GENE THERAPY, 2021-2026 (IN $ MILLION)

FIGURE 29: UNITED STATES PRECISION MEDICINE MARKET, BY PRECISION DIAGNOSTICS, 2021-2026 (IN $ MILLION)

FIGURE 30: UNITED STATES PRECISION DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2026 (IN $ MILLION)

FIGURE 31: UNITED STATES MOLECULAR DIAGNOSTICS MARKET, BY NON-INVASIVE PRENATAL TESTING (NIPT), 2021-2026 (IN $ MILLION)

FIGURE 32: UNITED STATES MOLECULAR DIAGNOSTICS MARKET, BY COMPANION DIAGNOSTICS, 2021-2026 (IN $ MILLION)

FIGURE 33: UNITED STATES MOLECULAR DIAGNOSTICS MARKET, BY LIQUID BIOPSY, 2021-2026 (IN $ MILLION)

FIGURE 34: UNITED STATES MOLECULAR DIAGNOSTICS MARKET, BY OTHER MOLECULAR DIAGNOSTICS, 2021-2026 (IN $ MILLION)

FIGURE 35: UNITED STATES PRECISION DIAGNOSTICS MARKET, BY MEDICAL IMAGING, 2021-2026 (IN $ MILLION)

FIGURE 36: UNITED STATES MEDICAL IMAGING MARKET, BY IMAGING ANALYTICS, 2021-2026 (IN $ MILLION)

FIGURE 37: UNITED STATES MEDICAL IMAGING MARKET, BY IMAGING COMPUTER-AIDED DETECTION (CADX), 2021-2026 (IN $ MILLION)

FIGURE 38: UNITED STATES PRECISION MEDICINE MARKET, BY DIGITAL HEALTH AND INFORMATION TECHNOLOGY, 2021-2026 (IN $ MILLION)

FIGURE 39: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY CLINICAL DECISION SUPPORT SYSTEMS (CDSS), 2021-2026 (IN $ MILLION)

FIGURE 40: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY BIG DATA ANALYTICS, 2021-2026 (IN $ MILLION)

FIGURE 41: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IT INFRASTRUCTURE, 2021-2026 (IN $ MILLION)

FIGURE 42: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY GENOMICS INFORMATICS, 2021-2026 (IN $ MILLION)

FIGURE 43: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IN-SILICO INFORMATICS, 2021-2026 (IN $ MILLION)

FIGURE 44: UNITED STATES DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY MOBILE HEALTH, 2021-2026 (IN $ MILLION)

Request For A Free Sample